F.D.A. Approves Muscular Dystrophy Drug That Patients Lobbied For

The decision went against the recommendation of independent experts, and the agency is requiring an additional trial to confirm effectiveness.

from NYT > Health http://ift.tt/2cOkVkt
via health&fitness